Skip to content
Screener

Tectonic Therapeutics TECX Price / book

Price / book at other companies

ALN
Alnylam PharmaceuticalsALNY
29.7×-139×
Septerna, Inc. logo
Septerna, Inc.SEPN
3.9×+2.6×
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
6.8×-0.7×
Regenxbio logo
RegenxbioRGNX
8.6×+6.6×
Opko Health logo
Opko HealthOPK
1×+0.2×
Celcuity logo
CelcuityCELC
103.1×+98.7×

Other financials

Income statement

See full
Operating income-$27.3M-49.2%
Net income-$25.2M-58.7%
EPS (diluted)-$1.34-44.1%

Balance sheet

See full
Cash & equivalents$236.9M-22.8%
Total debt$4.9M+86.1%
Total equity$230.4M-23.5%
Total assets$246.6M-21.7%

Cash flow

See full
Operating cash flow-$18.4M-40.7%
CapEx$19.0K-29.6%
Free cash flow-$18.4M-40.6%

Valuation

See full
Market cap$639.46M+54.6%
Enterprise value$407.46M+219%

Returns & leverage

See full
Return on equity-31.4%—
Debt / equity0×0.0×
Current ratio18.5×-4.4×

Where this comes from

Calculated from Tectonic Therapeutics’s reported figures.

market cap/total stockholders equity=2.5×

Based on the most recent quarter.

The source filing: Tectonic Therapeutics’s 10-Q, filed May 7, 2026. Open the filing →

Filed
May 7, 2026, 4:19 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-212016

FAQ

What is Tectonic Therapeutics's price / book?
Tectonic Therapeutics (TECX) reported price / book of 2.5× in Q1 2026.
How has Tectonic Therapeutics's price / book changed year-over-year?
Tectonic Therapeutics's price / book increased by 129.4% year-over-year, from 1.1× to 2.5×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Tectonic Therapeutics's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude